Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
4
×
national top stories
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
startups
wisconsin blog main
wisconsin top stories
abbvie
acorda therapeutics
acute myeloid leukemia
adverum biotechnologies
aiq solutions
alder biopharmaceuticals
ambit biosciences
amgen
ampyra
apokyn
apomorphine
athena countouriotis
baird capital
beringea
boulder/denver blog main
boulder/denver top stories
brett zbar
brian stern
bristol-myers squibb
calcitonin gene-related peptide
centers for medicare & medicaid services
chronic migraine
cms
cormorant asset management
daiichi sankyo
What
gets
4
×
new
4
×
drug
fda
medical
nod
patients
acorda
amgen
app
approval
approved
athena
biotech
cancer
candidates
cash
ceo
chief
class
cope
countouriotis
developed
development
device
disease
disorders
economic
episodes
financing
friday
head
help
influx
late
life
looms
lüm
meant
medications
Language
Current search:
gets
×
new
×
" national blog main "
×
@xconomy.com
4 years ago
WI Watchlist: Montage, LÜM, WEDC, Titan Spine, Polco, Swallow & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
